Risk factors for bleeding in haemato-oncology patients—a nested case–control study: The BITE study protocol (Bleeding In Thrombocytopenia Explained)

INTRODUCTION: Haemato-oncological patients often receive platelet count driven prophylactic platelet transfusions to prevent bleeding. However, many prophylactically transfused patients still bleed. More knowledge on risk factors for bleeding is therefore needed. This will enable identification of b...

Descripción completa

Detalles Bibliográficos
Autores principales: Cornelissen, Loes L, Caram-Deelder, Camila, van der Bom, Johanna G, Middelburg, Rutger A, Zwaginga, Jaap Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7328810/
https://www.ncbi.nlm.nih.gov/pubmed/32606056
http://dx.doi.org/10.1136/bmjopen-2019-034710

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7328810/
https://www.ncbi.nlm.nih.gov/pubmed/32606056
http://dx.doi.org/10.1136/bmjopen-2019-034710

Ejemplares similares